logo
Seoul shares end tad higher on overnight US gains, rate cut hopes

Seoul shares end tad higher on overnight US gains, rate cut hopes

Korea Herald7 days ago
South Korean stocks finished slightly higher Wednesday, tracking overnight US stocks gains boosted by eased Middle Eastern tensions and hopes of an early interest rate cut by the Federal Reserve. The local currency fell against the US dollar.
The benchmark Korea Composite Stock Price Index rose 4.61 points, or 0.15 percent, to close at 3,108.25.
Trade volume was heavy at 624.7 million shares worth 18.7 trillion won ($13.7 billion), with winners outnumbering losers 466 to 420.
Foreigners and institutions sold a combined 692.2 billion won worth of local stocks, while retail investors bought shares worth 751.1 billion won.
Overnight, Wall Street gained ground as investors focused on easing tensions in the Middle East following a ceasefire between Israel and Iran, and the possibility of an early interest rate cut raised by US Federal Reserve Chair Jerome Powell during testimony at the U.S Congress.
Han Ji-young, an analyst at Kiwoom Securities, noted that the market may face hurdles in further advancing as the KOSPI had surpassed the 3,100 mark at a much faster speed than expected.
"It is important to consider that the market may be affected by macro factors such as tariffs and the Fed's policy," Han said.
The market advance was led by chipmakers and automakers.
Market heavyweight Samsung Electronics added 1.32 percent to end at 61,300 won, and chip rival SK hynix jumped 2.69 percent to 286,000 won.
Automotive and steel shares also enjoyed brisk trading. Top automaker Hyundai Motor soared 5.34 percent to 217,000 won, and leading steelmaker POSCO Holdings climbed 2.47 percent to 269,500 won.
Kakao Pay extended its gains rising 1.96 percent to finish at 93,800 won, on hopes that the online lender could benefit from the government's push to adopt won-pegged stablecoins.
In contrast, financial and internet portal shares retreated.
KB Financial dropped 2.49 percent to 109,500 won, and top portal operator Naver slumped 2.41 percent to 283,500 won. Leading battery manufacturer LG Energy Solution lost 0.83 percent to finish at 298,000 won.
The local currency was trading at 1,362.4 won against the greenback at 3:30 p.m., down 2.2 won from the previous session. (Yonhap)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

[Editorial] Stablecoins, unstable ground
[Editorial] Stablecoins, unstable ground

Korea Herald

time6 hours ago

  • Korea Herald

[Editorial] Stablecoins, unstable ground

Korea must weigh the risks and rewards of stablecoins amid intensifying dispute In Seoul's financial circles, a new image is emerging: a digital coin emblazoned with the South Korean flag, suspended somewhere between statecraft and speculation. Once a fringe idea among cryptocurrency enthusiasts, the notion of a won-backed stablecoin has moved to the center of the country's monetary policy debate. What appears to be a pragmatic embrace of innovation conceals deeper tensions about the architecture of money, institutional trust and the evolving role of central banks in a digitized economy. At the core of the issue lies a contradiction. President Lee Jae Myung's administration has pledged to foster a stablecoin ecosystem to keep pace with global developments and safeguard monetary sovereignty. The ruling Democratic Party of Korea is advancing legislation to allow private companies — with as little as 10 billion won ($7.4 million) in capital — to issue coins fully backed by the Korean won. Major banks are already registering trademarks and forming blockchain partnerships. Related equities are climbing on speculative enthusiasm. Yet as momentum builds, the Bank of Korea is applying the brakes. Its own pilot project for a central bank digital currency, once touted as a state-led alternative to private stablecoins, has lost traction after years of investment. The central bank, once positioned to shape the digital finance agenda, now finds itself increasingly marginalized. Officials warn that if the market is flooded with privately issued pseudo-money, the bank's ability to manage interest rates, control liquidity and maintain financial stability could be severely compromised. These concerns are not theoretical. The global stablecoin market is overwhelmingly dominated by dollar-based tokens such as USDT and USDC, which account for over 99 percent of transaction volume. Proponents of a Korean alternative argue that without a domestic option, the country risks capital flight and diminished control over trade settlement. But these arguments remain speculative. The BOK, echoing the Bank for International Settlements, has repeatedly cautioned that stablecoins issued by private firms — even when pegged to fiat currencies — pose systemic risks. These include liquidity mismatches, opaque reserves and the danger of a 'coin run' in which investor panic depletes backing assets and triggers broader financial contagion. The collapse of Terra-Luna in 2022 still casts a long shadow over the debate. Procedurally, the rush toward legislation raises additional concerns. Multiple competing bills are circulating in the National Assembly. Oversight is fragmented among the BOK, the Financial Services Commission and the Ministry of Economy and Finance, with no unified strategy in place. The absence of robust consumer protections, capital requirements and clear supervisory authority underscores the lack of regulatory preparedness. Reports that the Presidential Commission on Policy Planning has urged the BOK to 'show flexibility' and devise alternatives reflect mounting political pressure on the central bank to step aside. This disjointed approach points to a deeper dilemma. South Korea seeks to lead in digital finance but remains uncertain about how monetary authority should be shared — or defended — in an era of decentralization. The CBDC's limited progress reflects institutional inertia in the face of rapid technological disruption. Meanwhile, private sector players are advancing with greater speed, louder voices and fewer constraints. The implications extend beyond implementation. A poorly regulated stablecoin framework could distort trade data, fuel asset bubbles and erode trust in the won. Yet delaying reform risks entrenching dollar dependence and leaving South Korea behind in emerging payment systems. The task is to permit innovation while preserving accountability and credibility. South Korea is not wrong to explore stablecoins. But it is wrong to move without a cohesive plan. True stability is not found in code or collateral alone, but in the strength of the institutions that stand behind them.

Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics
Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics

Korea Herald

time13 hours ago

  • Korea Herald

Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics

SEOUL, South Korea, July 1, 2025 /PRNewswire/ -- Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, announced today the launch of STAgora™, a next-generation platform for infectious disease analytics. Designed as a real-time infectious disease intelligence system, the platform combines diagnostic data with advanced statistical modeling and aims to redefine how the world detects, tracks, and responds to outbreaks. STAgora™ provides real-time global visualization of infectious disease trends at the municipal, national, and continental levels, based on actual diagnostic test results. The platform delivers healthcare professionals immediate, structured diagnostic reports and statistical analyses in clear, actionable formats. These are supported by customizable dashboards and real-time alert functions. In addition to tracking individual cases, STAgora™ enables users to monitor outbreaks across selected regions, both local and international. This capability provides real-time visibility into disease spread, enhancing situational awareness and supporting timely, data-driven public health responses. By equipping national and global health authorities with real-time epidemiological insight, the platform is expected to strengthen decision-making and support the development of effective response strategies to mitigate large-scale infectious disease outbreaks. With more than 40 built-in statistical tools, STAgora™ enables early detection of abnormal pathogen patterns and supports predictive modeling for seasonal trends and emerging outbreaks. These tools include modules for tracking individual infections, analyzing symptom-based co-infections and calculating real-time infection rate trends. Together, they help transform static data into forward-looking intelligence that guides proactive interventions. Unlike traditional outbreak monitoring systems that rely on retrospective data, STAgora™ performs real-time analysis of PCR-derived diagnostics. This allows for immediate visibility into pathogen spread and, through AI-based algorithms, the forecasting of potential future outbreaks. "The key differentiator of STAgora™ is its unique architecture, which aggregates real-time diagnostic data from around the world into a unified analysis platform," said Young-Seag Baeg, head of strategic planning at Seegene. When paired with Seegene's proprietary syndromic quantitative PCR technology, STAgora™ offers expanded visibility into both single-pathogen infections and simultaneous multi-pathogen co-infections. This comprehensive diagnostic insight empowers clinicians to make faster, more informed decisions at the point of care. "During the COVID-19 pandemic, we saw firsthand how crucial accurate and timely interpretation of diagnostic data was in shaping public health policies and clinical outcomes," said Daniel Shin, executive vice president and chief global sales and marketing officer at Seegene. "Now, as we confront increasingly complex threats such as antimicrobial resistance, viral mutations and co-infections, the ability to deliver actionable insights from diagnostic data is becoming a cornerstone of clinical innovation and a vital pillar of global health security." Seegene will officially debut STAgora™ at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) annual meeting, taking place July 27 to 31 in Chicago, USA. The event will highlight key capabilities of the platform, including its integration with CURECA™, Seegene's fully automated, unmanned PCR system. ADLM 2025 will also serve as a launchpad for Seegene to explore global collaboration and partnerships with healthcare leaders and clients. With the launch of STAgora™, Seegene aims to lay the foundation for a smarter, faster and more connected global health defense system. By combining real-time molecular diagnostics, AI-driven analytics and global data integration, STAgora™ represents a strategic step toward building an intelligent public health infrastructure capable of responding proactively to emerging threats. The company envisions the platform as a core pillar of the global infectious disease response framework, marking a new step toward enhanced diagnostic insight and preparedness. About Seegene Seegene has more than 20 years of dedicated experience in R&D, manufacturing, and business related to syndromic real-time PCR technologies. This expertise was particularly highlighted during the COVID-19 pandemic when Seegene provided over 340 million COVID-19 tests to more than 100 countries worldwide. The core feature of Seegene's syndromic real-time PCR technology is the ability to simultaneously test for 14 pathogens that cause similar signs and symptoms in a single tube with quantitative information. CURECA™(Continuous, Unlimited, Random-access, Expandable, and Customizable Automation) is a fully automated and modular PCR system that eliminates manual processes and enables continuous, real-time testing. It is a unified platform designed to operate continuously, 24 hours a day, with no human intervention. The very core feature is CPS which is the first part of CURECA™, the world's first automated pre-treatment system capable of handling a full spectrum of specimen types, including blood, stool, sputum, and urine. Designed to support both centralized and decentralized labs, CURECA offers scalable automation and flexible adoption—making it especially valuable in settings with limited space or personnel.

Seoul shares rise for 2nd day on hopes for US tariff talks, Commercial Act revision
Seoul shares rise for 2nd day on hopes for US tariff talks, Commercial Act revision

Korea Herald

time19 hours ago

  • Korea Herald

Seoul shares rise for 2nd day on hopes for US tariff talks, Commercial Act revision

South Korean stocks rose for a second straight session Tuesday as investors welcomed signs of progress in trade talks over the United States' tariff scheme and were keen on a potential revision of a shareholders-friendly law. The local currency fell against the US dollar. The benchmark Korea Composite Stock Price Index added 17.95 points, or 0.58 percent, to close at 3,089.65. Trade volume was moderate at 563.22 million shares worth 14.99 trillion won ($11.05 billion), with winners beating losers 706 to 185. Institutional and foreign investors bought a net 474.96 billion won and 180.7 billion won worth of stocks, respectively, while individuals net sold 637.69 billion won. The index opened higher, tracking overnight gains on Wall Street, and climbed further to hit a yearly high before paring some of its earlier gains. Investor sentiment was buoyed by signs of progress in trade talks between the US and Canada, as well as other trading partners, and by the possibility that the Federal Reserve may resume interest rate cuts. These factors pushed the S&P 500 and the tech-heavy Nasdaq to all-time highs on Monday (US time). Investors also closely watched the potential revision of the Commercial Act, which calls for expanding corporate directors' fiduciary duty to shareholders to better protect the rights of minority shareholders. The ruling Democratic Party has been pushing for the amendment, while the main opposition People Power Party has shifted its stance and pledged to review it favorably. Top cap shares finished mixed. Market bellwether Samsung Electronics soared 1.59 percent to 60,750 won, while chip giant SK hynix sank 1.28 percent to 288,250 won on profit taking. Major battery maker LG Energy Solution added 0.76 percent to 299,250 won, and No. 1 steelmaker POSCO Holdings spiked 5.75 percent to 276,000 won. Nuclear power plant manufacturer Doosan Enerbility shed 1.02 percent to 67,700 won following sharp gains in the previous session. Bio shares gathered ground. Leading biotech firm Samsung Biologics advanced 0.71 percent to 999,000 won, and Celltrion went up 0.31 percent to 160,100 won. Top carmaker Hyundai Motor surged 1.47 percent to 206,500 won, and its sister Kia Motors jumped 1.75 percent to 98,600 won. Leading financial firm KB Financial gained 0.81 percent to 111,800 won, and defense giant Hanwha Aerospace increased 0.47 percent to 852,000 won. Top online portal operator Naver rose 0.57 percent to 264,000 won, while Kakao, the operator of the country's dominant mobile messenger, climbed 2.33 percent to 61,400 won. The local currency was quoted at 1,350 won against the greenback at 3:30 p.m., down 5.9 won from the previous session. Bond prices, which move inversely to yields, closed mixed. The yield on three-year Treasurys rose 0.2 basis point to 2.454 percent, and the return on the benchmark five-year government bonds declined 1.0 basis points to 2.581 percent. (Yonhap)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store